Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin

American Journal of Pathology

Volumn 180, Issue 6, 2012, Pages 2440-2451

  Zhu, Junfeng ^a   Feng, Yupeng ^b   Ke, Zunfu ^a,c   Yang, Zheng ^a,c   Zhou, Junyi ^c   Huang, Xiaorong ^c   Wang, Liantang ^a,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; MICRORNA; MICRORNA 183; PROTEIN P42; PROTEIN P44; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE SILENCING; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MALE; METASTASIS; METASTASIS INHIBITION; OSTEOSARCOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CYTOSKELETAL PROTEINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OSTEOSARCOMA; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UP-REGULATION; YOUNG ADULT;

EID: 84861626895     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.02.023     Document Type: Article

References (50)

1. M.P. Link, A.M. Goorin, A.W. Miser, A.A. Green, C.B. Pratt, J.B. Belasco, J. Pritchard, J.S. Malpas, A.R. Baker, J.A. Kirkpatrick The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity N Engl J Med 314 1986 1600 1606
2. P.A. Meyers, G. Heller, J. Healey, A. Huvos, J. Lane, R. Marcove, A. Applewhite, V. Vlamis, G. Rosen Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience J Clin Oncol 10 1992 5 15
3. P.A. Meyers, R. Gorlick Osteosarcoma Pediatr Clin North Am 44 1997 973 989
4. G. Bacci, M. Mercuri, A. Briccoli, S. Ferrari, F. Bertoni, D. Donati, C. Monti, A. Zanoni, C. Forni, M. Manfrini Osteogenic sarcoma of the extremity with detectable lung metastases at presentation Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions Cancer 79 1997 245 254
5. G. Bacci, A. Longhi, M. Versari, M. Mercuri, A. Briccoli, P. Picci Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution Cancer 106 2006 1154 1161
6. R. Visone, C.M. Croce miRNAs and cancer Am J Pathol 174 2009 1131 1138
7. G.A. Calin, C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 2006 857 866
8. M.S. Nicoloso, R. Spizzo, M. Shimizu, S. Rossi, G.A. Calin MicroRNAs - the micro steering wheel of tumour metastases Nat Rev Cancer 9 2009 293 302
9. L. Ma, J. Young, H. Prabhala, E. Pan, P. Mestdagh, D. Muth, J. Teruya-Feldstein, F. Reinhardt, T.T. Onder, S. Valastyan, F. Westermann, F. Speleman, J. Vandesompele, R.A. Weinberg miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis Nat Cell Biol 12 2010 247 256
10. L. Ma, J. Teruya-Feldstein, R.A. Weinberg Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 2007 682 688
11. M. Sachdeva, Y.Y. Mo MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1 Cancer Res 70 2010 378 387
12. X.F. Li, P.J. Yan, Z.M. Shao Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer Oncogene 28 2009 3937 3948
13. H. Wu, S. Zhu, Y.Y. Mo Suppression of cell growth and invasion by miR-205 in breast cancer Cell Res 19 2009 439 448
14. J.D. Roybal, Y. Zang, Y.H. Ahn, Y. Yang, D.L. Gibbons, B.N. Baird, C. Alvarez, N. Thilaganathan, D.D. Liu, P. Saintigny, J.V. Heymach, C.J. Creighton, J.M. Kurie miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1 Mol Cancer Res 9 2011 25 35
15. Y. Li, T.G. Vandenboom 2nd, Z. Wang, D. Kong, S. Ali, P.A. Philip, F.H. Sarkar miR-146a suppresses invasion of pancreatic cancer cells Cancer Res 70 2010 1486 1495
16. D. Kong, Y. Li, Z. Wang, S. Banerjee, A. Ahmad, H.R. Kim, F.H. Sarkar miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells Stem Cells 27 2009 1712 1721
17. J. Tie, Y. Pan, L. Zhao, K. Wu, J. Liu, S. Sun, X. Guo, B. Wang, Y. Gang, Y. Zhang, Q. Li, T. Qiao, Q. Zhao, Y. Nie, D. Fan miR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor PLoS Genet 6 2010 e1000879
18. M. Shu, X. Zheng, S. Wu, H. Lu, T. Leng, W. Zhu, Y. Zhou, Y. Ou, X. Lin, Y. Lin, D. Xu, Y. Zhou, G. Yan Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells Mol Cancer 10 2011 59
19. I.A. Asangani, S.A. Rasheed, D.A. Nikolova, J.H. Leupold, N.H. Colburn, S. Post, H. Allgayer MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer Oncogene 27 2008 2128 2136
20. M. Osaki, F. Takeshita, Y. Sugimoto, N. Kosaka, Y. Yamamoto, Y. Yoshioka, E. Kobayashi, T. Yamada, A. Kawai, T. Inoue, H. Ito, M. Oshimura, T. Ochiya MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression Mol Ther 19 2011 1123 1130
21. R.K. Yantiss, M. Goodarzi, X.K. Zhou, H. Rennert, E.C. Pirog, B.F. Banner, Y.T. Chen Clinical, pathologic, and molecular features of early-onset colorectal carcinoma Am J Surg Pathol 33 2009 572 582
22. A.L. Sarver, L. Li, S. Subramanian MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration Cancer Res 70 2010 9570 9580
23. G. Wang, W. Mao, S. Zheng MicroRNA-183 regulates Ezrin expression in lung cancer cells FEBS Lett 582 2008 3663 3668
24. A.J. Lowery, N. Miller, R.M. Dwyer, M.J. Kerin Dysregulated miR-183 inhibits migration in breast cancer cells BMC Cancer 10 2010 502
25. G. Li, C. Luna, J. Qiu, D.L. Epstein, P. Gonzalez Targeting of integrin beta1 and kinesin 2alpha by microRNA 183 J Biol Chem 285 2010 5461 5471
26. J. Li, H. Fu, C. Xu, Y. Tie, R. Xing, J. Zhu, Y. Qin, Z. Sun, X. Zheng miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells BMC Cancer 10 2010 354
27. Y.W. Chu, P.C. Yang, S.C. Yang, Y.C. Shyu, M.J. Hendrix, R. Wu, C.W. Wu Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line Am J Respir Cell Mol Biol 17 1997 353 360
28. C.C. Wang, M.F. Tsai, T.H. Dai, T.M. Hong, W.K. Chan, J.J. Chen, P.C. Yang Synergistic activation of the tumor suppressor HLJ1, by the transcription factors YY1 and activator protein 1 Cancer Res 67 2007 4816 4826
29. M.S. Kim, W.S. Song, W.H. Cho, S.Y. Lee, D.G. Jeon Ezrin expression predicts survival in stage IIB osteosarcomas Clin Orthop Relat Res 459 2007 229 236
30. J.C. Barros, C.J. Marshall Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton J Cell Sci 118 2005 1663 1671
31. Y. Ward, W. Wang, E. Woodhouse, I. Linnoila, L. Liotta, K. Kelly Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways Mol Cell Biol 21 2001 5958 5969
32. K. Krishnan, B. Bruce, S. Hewitt, D. Thomas, C. Khanna, L.J. Helman Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway Clin Exp Metastasis 23 2006 227 236
33. M. Kansara, D.M. Thomas Molecular pathogenesis of osteosarcoma DNA Cell Biol 26 2007 1 18
34. R. Gorlick, P. Anderson, I. Andrulis, C. Arndt, G.P. Beardsley, M. Bernstein, J. Bridge, N.K. Cheung, J.S. Dome, D. Ebb, T. Gardner, M. Gebhardt, H. Grier, M. Hansen, J. Healey, L. Helman, J. Hock, J. Houghton, P. Houghton, A. Huvos, C. Khanna, M. Kieran, E. Kleinerman, M. Ladanyi, C. Lau, D. Malkin, N. Marina, P. Meltzer, P. Meyers, D. Schofield, C. Schwartz, M.A. Smith, J. Toretsky, M. Tsokos, L. Wexler, J. Wigginton, S. Withrow, M. Schoenfeldt, B. Anderson Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary Clin Cancer Res 9 2003 5442 5453
35. J. Li, P. Smyth, R. Flavin, S. Cahill, K. Denning, S. Aherne, S.M. Guenther, J.J. O'Leary, O. Sheils Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells BMC Biotechnol 7 2007 36
36. Y. Xi, G. Nakajima, E. Gavin, C.G. Morris, K. Kudo, K. Hayashi, J. Ju Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples RNA 13 2007 1668 1674
37. M. Glud, M. Klausen, R. Gniadecki, M. Rossing, N. Hastrup, F.C. Nielsen, K.T. Drzewiecki MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling J Invest Dermatol 129 2009 1219 1224
38. K.W. Hunter Ezrin, a key component in tumor metastasis Trends Mol Med 10 2004 201 204
39. B.E. Elliott, J.A. Meens, S.K. SenGupta, D. Louvard, M. Arpin The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells Breast Cancer Res 7 2005 R365 R373
40. W.H. Weng, J. Ahlen, K. Astrom, W.O. Lui, C. Larsson Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas Clin Cancer Res 11 2005 6198 6204
41. C. Khanna, X. Wan, S. Bose, R. Cassaday, O. Olomu, A. Mendoza, C. Yeung, R. Gorlick, S.M. Hewitt, L.J. Helman The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nat Med 10 2004 182 186
42. S. Griffiths-Jones, R.J. Grocock, S. van Dongen, A. Bateman, A.J. Enright miRBase: microRNA sequences, targets and gene nomenclature Nucleic Acids Res 34 2006 D140 D144
43. A. Krek, D. Grun, M.N. Poy, R. Wolf, L. Rosenberg, E.J. Epstein, P. MacMenamin, I. da Piedade, K.C. Gunsalus, M. Stoffel, N. Rajewsky Combinatorial microRNA target predictions Nat Genet 37 2005 495 500
44. B.P. Lewis, I.H. Shih, M.W. Jones-Rhoades, D.P. Bartel, C.B. Burge Prediction of mammalian microRNA targets Cell 115 2003 787 798
45. C. Folio, M.I. Mora, M. Zalacain, F.J. Corrales, V. Segura, L. Sierrasesumaga, G. Toledo, M. San-Julian, A. Patino-Garcia Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets J Proteome Res 8 2009 3882 3888
46. Y. Meng, Z. Lu, S. Yu, Q. Zhang, Y. Ma, J. Chen Ezrin promotes invasion and metastasis of pancreatic cancer cells J Transl Med 8 2010 61
47. G. Bacci, A. Briccoli, S. Ferrari, A. Longhi, M. Mercuri, R. Capanna, D. Donati, S. Lari, C. Forni, M. DePaolis Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol Eur J Cancer 37 2001 2030 2039
48. S.S. Bielack, B. Kempf-Bielack, G. Delling, G.U. Exner, S. Flege, K. Helmke, R. Kotz, M. Salzer-Kuntschik, M. Werner, W. Winkelmann, A. Zoubek, H. Jurgens, K. Winkler Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols J Clin Oncol 20 2002 776 790
49. A.J. Provisor, L.J. Ettinger, J.B. Nachman, M.D. Krailo, J.T. Makley, E.J. Yunis, A.G. Huvos, D.L. Betcher, E.S. Baum, C.T. Kisker, J.S. Miser Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group J Clin Oncol 15 1997 76 84
50. R.L. Souhami, A.W. Craft, J.W. Van der Eijken, M. Nooij, D. Spooner, V.H. Bramwell, R. Wierzbicki, A.J. Malcolm, A. Kirkpatrick, B.M. Uscinska, M. Van Glabbeke, D. Machin Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup Lancet 350 1997 911 917